Kalytera Announces Engagement of Echelon Wealth Partners to Assist with Review of Potential Out-License Opportunities for Commercial Rights to GVHD Products Cannabis Investing News
PreveCeutical Granted Approval to Acquire and Use Human Mucosal Tissue for Final Phase of Sol-Gel Program Biotech Investing
MediPharm Labs Announces Addition to $1.2B MJ ETFMG Alternative Harvest ETF (USA) Cannabis Investing News
Lexaria Bioscience and Nuka Enterprises’ 1906 Expand Cannabis Product Relationship Cannabis Investing News
Life Science Big News Roundup: Biocure Enters into Exclusive Joint R&D Agreement with Pharos Vaccine Inc.; Bondarenko Acquires 14.48% Beneficial Ownership of BriaCell; Lexaria’s DehydraTECHTM Formulation Delivers 475% More CBD to Bloodstream after 15 Minutes than Conventional Industry Formulations Life Science Investing
Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose Contraceptive Patch, Pharmaceutical Investing
Immutep Announces Data from Ongoing TACTI-mel Phase I Clinical Trial in Unresectable or Metastatic Melanoma Biotech Investing
Aura Announces Strategic Entry Into the European Market With the Closing of the Acquisition of Pharmadrug Cannabis Investing News
